TCR-Engineered Lymphocytes Targeting NY-ESO-1: In Vitro Assessment of Cytotoxicity against Tumors.
Alsalloum A, Alrhmoun S, Shevchenko J, Fisher M, Philippova J, Perik-Zavodskii R, Perik-Zavodskaia O, Lopatnikova J, Kurilin V, Volynets M, Akahori Y, Shiku H, Silkov A, Sennikov S.
Alsalloum A, et al.
Biomedicines. 2023 Oct 16;11(10):2805. doi: 10.3390/biomedicines11102805.
Biomedicines. 2023.
PMID: 37893178
Free PMC article.